TY - JOUR
T1 - Selective changes in thalamic and cortical GABAA receptor subunits in a model of acquired absence epilepsy in the rat
AU - Li, Huifang
AU - Kraus, Alli
AU - Wu, Jie
AU - Huguenard, John R.
AU - Fisher, Robert S.
N1 - Funding Information:
R.S.F. was supported by the Maslah Saul MD Chair and the James and Carrie Anderson Fund for Epilepsy Research. H.L. was supported by the Susan Horngren Fund and the Epilepsy Foundation. J.R.H. was supported by NIH RO1 NS34774. We gratefully acknowledge Wyeth-Ayerst for supplying the AY-9944 drug for the study and Dr. Mark Kay for the loan of laboratory equipment.
PY - 2006/7
Y1 - 2006/7
N2 - Neonatal treatment of Long-Evans Hooded rats with the cholesterol synthesis inhibitor (CSI) AY9944 has been shown to increase occurrence of spike-waves in EEG recordings and decrease benzodiazepines sensitivity of GABAA receptor-mediated responses in neurons from the thalamic reticular nuclei (nRt, Wu et al., 2004). The present experiments were designed to investigate the changes in the γ2 and α1 subunits of the GABAA receptor in CSI model rats as possible mechanisms of these changes. Western blot, immunohistochemistry and real-time PCR techniques were performed to measure the levels of GABAA receptor γ2 and α1 subunit transcripts and protein in the nRt and ventrobasal (VB) relay nuclei of thalamus and in somatosensory cortex. In CSI model animals, Western blot results showed that γ2 subunit expression significantly decreased in thalamus (control, n = 6: 0.17 ± 0.02 relative to actin vs. CSI model, n = 6: 0.11 ± 0.01, P < 0.05) but neither in cortex nor in hippocampal tissues. Conversely, α1 subunit expression decreased in CSI model somatosensory cortex, but not in nRt and VB. The present results demonstrate that neonatal block of cholesterol synthesis produces region- and subunit-specific decreases in GABAA receptor subunits in thalamus and cortex. Selective reductions in GABAA receptor subunits in thalamus may play a role in pathophysiology of absence epilepsy.
AB - Neonatal treatment of Long-Evans Hooded rats with the cholesterol synthesis inhibitor (CSI) AY9944 has been shown to increase occurrence of spike-waves in EEG recordings and decrease benzodiazepines sensitivity of GABAA receptor-mediated responses in neurons from the thalamic reticular nuclei (nRt, Wu et al., 2004). The present experiments were designed to investigate the changes in the γ2 and α1 subunits of the GABAA receptor in CSI model rats as possible mechanisms of these changes. Western blot, immunohistochemistry and real-time PCR techniques were performed to measure the levels of GABAA receptor γ2 and α1 subunit transcripts and protein in the nRt and ventrobasal (VB) relay nuclei of thalamus and in somatosensory cortex. In CSI model animals, Western blot results showed that γ2 subunit expression significantly decreased in thalamus (control, n = 6: 0.17 ± 0.02 relative to actin vs. CSI model, n = 6: 0.11 ± 0.01, P < 0.05) but neither in cortex nor in hippocampal tissues. Conversely, α1 subunit expression decreased in CSI model somatosensory cortex, but not in nRt and VB. The present results demonstrate that neonatal block of cholesterol synthesis produces region- and subunit-specific decreases in GABAA receptor subunits in thalamus and cortex. Selective reductions in GABAA receptor subunits in thalamus may play a role in pathophysiology of absence epilepsy.
KW - Absence epilepsy
KW - Cholesterol synthesis inhibitor
KW - GABA receptor subunit
KW - Somatosensory cortex
KW - Thalamic reticular nucleus
KW - Ventrobasal relay nucleus
UR - http://www.scopus.com/inward/record.url?scp=33745223261&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745223261&partnerID=8YFLogxK
U2 - 10.1016/j.neuropharm.2006.03.003
DO - 10.1016/j.neuropharm.2006.03.003
M3 - Article
C2 - 16678865
AN - SCOPUS:33745223261
SN - 0028-3908
VL - 51
SP - 121
EP - 128
JO - Neuropharmacology
JF - Neuropharmacology
IS - 1
ER -